Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease
about
M1 and M2 immune activation in Parkinson's Disease: Foe and ally?Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's diseaseParticulate matter neurotoxicity in culture is size-dependentBone marrow-derived mesenchymal stem cells increase dopamine synthesis in the injured striatum.Rgs6 is required for adult maintenance of dopaminergic neurons in the ventral substantia nigra.Renin angiotensin system and gender differences in dopaminergic degeneration.Mutations and binding sites of human transcription factorsSingle-molecule FRET studies on alpha-synuclein oligomerization of Parkinson's disease genetically related mutantsLaser capture microdissection protocol for gene expression analysis in the brain.Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: an intracellular renin-angiotensin system in the nigraRGS6 as a Novel Therapeutic Target in CNS Diseases and Cancer.Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinson's Disease.Morphological Changes in a Severe Model of Parkinson's Disease and Its Suitability to Test the Therapeutic Effects of Microencapsulated Neurotrophic Factors.Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat.Interaction between NADPH-oxidase and Rho-kinase in angiotensin II-induced microglial activation.LRRK2 in peripheral and central nervous system innate immunity: its link to Parkinson's disease.Basal Ganglia Circuits: What's Now and Next?4R-Cembranoid Improves Outcomes after 6-Hydroxydopamine Challenge in Both In vitro and In vivo Models of Parkinson's Disease.Local Cues Establish and Maintain Region-Specific Phenotypes of Basal Ganglia Microglia.Specificity of Pitx3-Dependent Gene Regulatory Networks in Subsets of Midbrain Dopamine Neurons.Does MPTP intoxication in mice induce metabolite changes in the nucleus accumbens? A ¹H nuclear MRS study.
P2860
Q27024667-D0D28CCF-B473-4F92-BDD8-133D9CA67FA9Q28074143-B78EE773-AFF0-4442-8DE9-B9A2CC60E37BQ34068032-BA93C856-C56D-4284-8D7B-CA90980733B4Q34358267-B428C589-3030-4D7F-9D62-6331EDDAFCE8Q34679823-EE8F134E-062D-4BB1-968A-3BC61B3B718BQ35203828-EA4EF13A-C4A4-4505-9725-1F7A9094544FQ36001687-8475DF33-04DE-42CF-A19D-9A3E2F2D52CEQ36298004-D3A78DF1-1651-47FA-B368-B1D91E548F1AQ36385775-38782996-68F6-44B7-8FA2-2A5F1D39F5AEQ36632049-64EF3123-CB6B-43D3-8839-2FEC22310A63Q37600399-43E4A6FD-DC3B-4331-9FB6-62C0BABC7881Q38260925-7C44B063-8DA2-4164-8129-E5A4A8765C27Q38731068-FDD847F9-660B-4679-80BE-1AC2A2E89475Q38912869-2C43B639-7643-47F6-AC7E-27A699BCAC73Q38942116-9C555962-9753-4547-BC2B-4A660E97E76DQ39137339-E418CE0D-CFBB-4DD7-A34D-8FD88DE85916Q41050952-8B5573E5-89FB-40B8-B487-F693883BC524Q42241279-C91CBB99-9C03-4865-82A7-422759695056Q42512130-584BA04E-AF96-40ED-98C2-BB45C6A8C9B4Q48116577-C0571242-5067-4EB1-BBB5-25D5F206BDAAQ48339373-D8AA2C7E-DF3A-4215-AC99-F0A302A9713A
P2860
Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease
@en
Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease.
@nl
type
label
Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease
@en
Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease.
@nl
prefLabel
Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease
@en
Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease.
@nl
P2093
P2860
P356
P1476
Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease
@en
P2093
Domingo Afonso-Oramas
Ignacio Cruz-Muros
Javier Castro-Hernandez
Josmar Salas-Hernandez
Tomás González-Hernández
P2860
P356
10.3389/FNANA.2010.00140
P577
2010-10-20T00:00:00Z